已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

A network meta‐analysis to compare glycaemic control in patients with type 2 diabetes treated with exenatide once weekly or liraglutide once daily in comparison with insulin glargine, exenatide twice daily or placebo

作者
David Alexander Scott,Kristina Secnik Boye,Louise Timlin,James F. Clark,Jennie H. Best
出处
期刊:Diabetes, Obesity and Metabolism [Wiley]
卷期号:15 (3): 213-223 被引量:65
标识
DOI:10.1111/dom.12007
摘要

AIMS: The glucagon-like peptide-1 receptor agonists (GLP-1 RAs) exenatide once weekly (ExQW) and liraglutide once daily (QD) are indicated to improve glycaemic control in patients with type 2 diabetes. Although glycaemic control with ExQW versus liraglutide QD 1.8 mg has been directly compared, no studies have compared ExQW with liraglutide QD 1.2 mg or determined the probable relative efficacies of various injectable therapies for glycaemic control; therefore, a network meta-analysis was performed to address these questions. METHODS: A systematic review identified randomized controlled trials of ≥24 weeks that compared ExQW, liraglutide QD (1.2 mg, 1.8 mg), insulin glargine, exenatide twice daily (ExBID), or placebo. Twenty-two studies evaluating 11 049 patients were included in the network meta-analysis. Mean differences in HbA1c relative to placebo or each other and probability rankings were estimated. RESULTS: Estimated mean differences in HbA1c versus placebo were -1.15% (95% CrI: -1.31 to -1.00) for ExQW, -1.01% (95% CrI: -1.18 to -0.85) for liraglutide 1.2 mg, and -1.18% (95% CrI: -1.32 to -1.04) for liraglutide 1.8 mg. HbA1c differences for ExQW versus liraglutide 1.2 mg and 1.8 mg were -0.14% (95% CrI: -0.34 to 0.06) and 0.03% (95% CrI: -0.14 to 0.18), respectively. The estimated mean difference in HbA1c between liraglutide 1.2 mg and 1.8 mg was 0.17% (95% CrI: 0.02-0.30). Results were consistent when adjusted for background antihyperglycaemic medications and diabetes duration. CONCLUSIONS: This network meta-analysis did not identify meaningful differences in HbA1c lowering between ExQW and both liraglutide doses, suggesting that these GLP-1 RAs have similar glycaemic effects.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
梁33完成签到,获得积分10
刚刚
刚刚
完美的睿渊完成签到,获得积分10
2秒前
2秒前
gqz完成签到,获得积分20
3秒前
maining完成签到,获得积分10
4秒前
huanhuan发布了新的文献求助10
4秒前
5秒前
6秒前
Milton_z完成签到 ,获得积分0
8秒前
车访枫发布了新的文献求助10
8秒前
12秒前
归尘发布了新的文献求助10
12秒前
15秒前
16秒前
16秒前
幽默果汁完成签到 ,获得积分10
16秒前
huanhuan完成签到,获得积分10
16秒前
华仔完成签到 ,获得积分10
16秒前
17秒前
热情善斓完成签到,获得积分10
18秒前
小二郎的应助被苹果思天采纳,获得10
18秒前
Maestro_S的应助被车访枫采纳,获得10
20秒前
21秒前
21秒前
22秒前
科研牛马完成签到,获得积分10
23秒前
24秒前
磊4165564发布了新的文献求助10
28秒前
30秒前
35秒前
曼波完成签到 ,获得积分10
35秒前
烟花的应助被可靠的公爵熊采纳,获得10
35秒前
小番茄完成签到 ,获得积分10
36秒前
wwwww完成签到 ,获得积分10
37秒前
李大海发布了新的文献求助10
39秒前
缥缈的凝丹完成签到,获得积分10
43秒前
时鸢完成签到,获得积分10
44秒前
45秒前
46秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158533
求助须知:如何正确求助?哪些是违规求助? 9554296
关于积分的说明 21718786
捐赠科研通 7747941
什么是DOI,文献DOI怎么找? 3427015
关于科研通互助平台的介绍 2551811
邀请新用户注册赠送积分活动 2471194